In a yearslong agreement, Medline will be the primary supplier for Cleveland-based O’Neill Healthcare. The prime vendor distribution agreement will cover O’Neill Healthcare’s six skilled nursing facilities, as well as its home health, hospice care and home medical equipment operations,…
Supply Chain
GE Healthcare and Nvidia have launched a collaboration to develop AI-powered autonomous X-ray and ultrasound technologies, with an aim to address growing radiology staff shortages and improve imaging efficiency. The partnership will leverage Nvidia’s AI computing platforms to enhance imaging…
Medtronic has recalled certain Pipeline Vantage Embolization Devices with Shield Technology due to an increased risk of incomplete wall apposition and braid deformation, which could lead to stroke or death. The FDA has classified this as the most serious type…
Pharmaceutical giant Merck will shut down its manufacturing site in Northumberland County, Pa., resulting in 163 job losses. Layoffs will happen in three phases with the first starting in May 2025, the second in June or July 2025 and the…
Smiths Medical has issued an urgent medical device correction for certain sizes of its Portex intubation oral/nasal endotracheal tubes due to a manufacturer defect that results in a smaller-than-expected diameter.
Advertisement
Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and Mesa, Ariz.
Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks.
A new study analyzing the FDA's Manufacturer and User Facility Device Experience database found that nearly one-third of medical device safety reports were not submitted within the 30-day timeframe or had "missing or invalid date data," according to the report.
House Republican leaders took steps this week to prevent a vote on ending President Donald Trump's tariffs on Mexico, Canada and China, The New York Times reported March 11.
Three former executives of Magellan Diagnostics, a North Billerica, Mass.-based medical device company, have pleaded guilty to charges related to concealing a malfunction in lead-testing devices that produced inaccurately low results for thousands of children and other patients.